Background Inhaled corticosteroids (ICS) are anti‐inflammatory drugs that have proven
benefits for people with worsening symptoms of chronic obstructive pulmonary disease …

Background Both inhaled steroids (ICS) and long‐acting beta 2‐agonists (LABA) are used in
the management of chronic obstructive pulmonary disease (COPD). This updated review …

Background Azithromycin is a macrolide antibiotic with anti-inflammatory and
immunomodulatory properties. We tested the hypothesis that azithromycin would decrease …

Although medical treatment of COPD has advanced, nonadherence to medication regimens
poses a significant barrier to optimal management. Underuse, overuse, and improper use …

Chronic obstructive pulmonary disease (COPD) poses a significant economic burden on
society, and a substantial portion is related to exacerbations of COPD. A literature review of …

Rationale: Unreported exacerbations and failure to seek medical attention may have
consequences on the health of patients with chronic obstructive pulmonary disease …

Long‐acting inhaled therapy (beta‐agonists, anticholinergics and steroids) for COPD: a
network meta‐analysis - Kew, KM - 2014 | Cochrane Library Skip to Content Cookies Our site …

Background Chronic obstructive pulmonary disease (COPD) is a respiratory disease that
causes progressive symptoms of breathlessness, cough and mucus build‐up. It is the fourth …

Background Both long‐acting beta 2‐agonists (LABA) and inhaled corticosteroids (ICS)
have been recommended in guidelines for the treatment of chronic obstructive pulmonary …

Background Both long‐acting beta 2‐agonists and inhaled corticosteroids have been
recommended in guidelines for the treatment of chronic obstructive pulmonary disease …